Whats new
Whats new.
goetzpartners securities - Efti-combo's boost efficacy of lung cancer standard of care; Reit Buy, A$2.88 tgt
May 29th 2023
This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.